Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model

In this study, we investigated efficacy of lenalidomide in combination with tumor antigen-loaded dendritic cells (DCs) in murine colon cancer model. MC-38 cell lines were injected subcutaneously to establish colon cancer-bearing mice. After tumor growth, lenalidomide (50 mg/kg/day) was injected intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Manh-Cuong, Nguyen-Pham, Thanh-Nhan, Lee, Hyun-Ju, Lakshmi, Thangaraj Jaya, Yang, Seoyun, Jung, Sung-Hoon, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432332/
https://www.ncbi.nlm.nih.gov/pubmed/28460478
http://dx.doi.org/10.18632/oncotarget.15917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432332/
https://www.ncbi.nlm.nih.gov/pubmed/28460478
http://dx.doi.org/10.18632/oncotarget.15917

Ejemplares similares